当前位置： SCI文献检索 > JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS期刊下所有文献 > G-CSF for the prophylaxis of neutropenic fever in patients with small cell lung cancer receiving myelosuppressive antineoplastic chemotherapy: meta-analysis and pharmacoeconomic evaluation.

G-CSF for the prophylaxis of neutropenic fever in patients with small cell lung cancer receiving myelosuppressive antineoplastic chemotherapy: meta-analysis and pharmacoeconomic evaluation.

Abstract：

:Standard meta-analytical and pharmacoeconomic techniques were used to study the clinical effectiveness and the cost-effectiveness ratio of the prophylactic (or pre-emptive) administration of G-CSF to patients with small cell lung cancer treated with conventional myelosuppressive cytotoxic chemotherapy. In the first part of our study, we conducted a meta-analysis of the randomized clinical trials evaluating G-CSF for this clinical indication. Three trials were identified by our literature search and were included in the meta-analysis (overall number of patients = 606). The end-points for evaluating G-CSF included mortality from infection and the cumulative incidence of neutropenic fever over six cycles of chemotherapy. The results of our meta-analysis demonstrate that prophylactic G-CSF did not affect mortality but significantly reduced the incidence of neutropenic fever from 68.3% to 38.7% (pooled odds ratio = 0.29, 95% CI: 0.21-0.40; P < 0.001). In the second part of our study, we carried out a pharmacoeconomic analysis to estimate the cost-effectiveness ratio of pre-emptive G-CSF (i.e. the 'average' cost associated with the prevention of an episode of neutropenic fever). This cost-effectiveness ratio was US$ 14,372 using the Italian price of the drug converted into dollars, or US$ 41 088 using the US price. Finally, we estimated the revenue-neutral price of G-CSF based on American data of the cost-of-illness. The price ranged from US$ 395 to US$ 569 per cycle, a figure higher than the value (US$ 150) previously reported in the literature.

journal_name

J Clin Pharm Ther

journal_title

Journal of clinical pharmacy and therapeutics

authors

Messori A,Trippoli S,Tendi E

doi

10.1111/j.1365-2710.1996.tb00001.x

subject

Has Abstract

pub_date

1996-04-01 00:00:00

pages

57-63

issue

2

eissn

0269-4727

issn

1365-2710

journal_volume

21

pub_type

杂志文章,meta分析

相关文献

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS文献大全
  • Iatrogenic Cushing's syndrome related to the interaction between oral budesonide with fluvoxamine: a case report.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Budesonide, an oral glucocorticoid indicated for the treatment of Crohn's disease, rarely interferes with the hypothalamic-pituitary-adrenal axis because more than 80% of it is metabolized by cytochrome P450 enzymes. CASE SUMMARY:A 33-year-old female patient diagnosed with Crohn's disease, ...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type：

    doi：10.1111/jcpt.12312

    authors： Martin CS,Blaga C,Lambrescu IM,Fierbințeanu-Braticevici C,Fica S

    更新日期：2015-10-01 00:00:00

  • Population pharmacokinetic investigation of digoxin in Japanese neonates.

    abstract：OBJECTIVE:To establish the role of patient characteristics in estimating doses of digoxin for neonates using routine therapeutic drug monitoring data. METHOD:The steady-state blood level data (n = 129) after repetitive oral administration in 71 hospitalized neonates were analysed using Nonlinear Mixed Effects Modellin...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/j.1365-2710.2007.00833.x

    authors： Yukawa E,Akiyama K,Suematsu F,Yukawa M,Minemoto M

    更新日期：2007-08-01 00:00:00

  • The use of prescription drugs among elderly Finnish men.

    abstract：:The extent and factors that influence drug use were studied in two rural cohorts of Finnish men. The men aged between 65 and 84 years belonged to the Finnish study population of the 25-year follow-up of the 'Seven Countries Study'. Of the original 1,711 men in 1959, 766 were still alive in 1984. The participation rate...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/j.1365-2710.1990.tb00365.x

    authors： Enlund H,Martikainen J,Turakka H,Nissinen A

    更新日期：1990-04-01 00:00:00

  • Case report of perforation of an ileal neobladder after treatment of rectal cancer with bevacizumab and comment on mechanisms of intestinal perforation associated with bevacizumab.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Bevacizumab is a monoclonal antibody that targets vascular endothelial growth factor (VEGF) that has activity in several types of malignancies. One of the uncommon adverse effects is spontaneous bowel perforation. In patients who have undergone cystectomy, a loop of small bowel is often used...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/j.1365-2710.2012.01343.x

    authors： Liu SV,Gollard R,Iqbal S

    更新日期：2012-10-01 00:00:00

  • Diphenhydramine dependence through deep intramuscular injection resulting in myonecrosis and prolonged QT interval.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Diphenhydramine (DPH) is a first-generation antihistamine, which is useful in treating allergic reaction, and is usually considered innocuous. We describe a retired nurse with history of depression, who began to develop drug-seeking behaviour after her first receiving of an intramuscular (IM...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/jcpt.12142

    authors： Chen TY,Yeh YW,Kuo SC,Chen CY,Lin TP,Chang CC

    更新日期：2014-06-01 00:00:00

  • Humanistic and economic outcomes of pharmacist-provided medication review in the community-dwelling elderly: A systematic review and meta-analysis.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Recent reviews have shown that pharmacist-provided medication review in the elderly can improve clinical outcomes and reduce medication discrepancies compared with usual care. However, none determined whether these translate to improved humanistic and economic outcomes. This review sought to...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章,meta分析,评审

    doi：10.1111/jcpt.12453

    authors： Loh ZW,Cheen MH,Wee HL

    更新日期：2016-12-01 00:00:00

  • Pharmacogenomic information in the Warning section of drug labels: A comparison between labels in the United States and those in five other countries/regions.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Clinically validated pharmacogenomic information useful for patient selection and/or dose adjustment is included in drug labels. However, the label information may differ among countries. This commentary summarizes the pharmacogenomic information on drug labels in different countries. COMME...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/jcpt.12691

    authors： Imatoh T,Sai K,Saito Y

    更新日期：2018-08-01 00:00:00

  • Pharmacokinetics of intravenous midazolam during epidural anaesthesia.

    abstract：:Midazolam concentration curves versus time were analysed in 10 otherwise healthy patients (ASA I-II) with inferior limb pathologies. The benzodiazepine was used as an adjuvant agent to epidural anaesthesia in view of its lower residual effect compared with other intravenous benzodiazepines. Midazolam pharmacokinetics...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/j.1365-2710.1991.tb00306.x

    authors： Sánchez-Alcaraz A,Sangrador G,Laguarda M,Quintana B

    更新日期：1991-06-01 00:00:00

  • An evaluation of the potential interaction between enalapril and amiloride.

    abstract：:Enalapril was shown to have no effect on the serum potassium of patients (n = 16) already taking Frusemide and Amiloride. Furthermore, there was no difference in serum potassium levels of the group taking a combination of Enalapril, Frusemide and Amiloride when compared to a similar group of patients taking Frusemide ...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/j.1365-2710.1987.tb00543.x

    authors： Radley AS,Fitzpatrick RW

    更新日期：1987-10-01 00:00:00

  • Paediatric acute kidney injury induced by vancomycin monotherapy versus combined vancomycin and meropenem.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Increasing reports of the combined use of vancomycin (VAN) and piperacillin/tazobactam leading to higher nephrotoxicity have led to carbapenems being recommended as an alternative option to combine with VAN when nephrotoxicity is a major concern. However, whether carbapenems also increase th...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/jcpt.12806

    authors： Zhang T,Cheng H,Li Y,Dong YZ,Zhang Y,Cheng XL,Wang AM,Dong YL

    更新日期：2019-06-01 00:00:00

  • Association of the clinical efficacy of vancomycin with the novel pharmacokinetic parameter area under the trough level (AUTL) in elderly patients with hospital-acquired pneumonia.

    abstract：WHAT IS KNOWN AND OBJECTIVE:The pharmacokinetic-pharmacodynamic parameter that best predicts the efficacy of vancomycin is the ratio of the area under the concentration versus time curve (AUC) to the minimum inhibitory concentration (MIC). A 24-h AUC (AUC24 )/MIC ratio ≥ 400 was recommended in an American consensus rev...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/jcpt.12399

    authors： Fukumori S,Tsuji Y,Mizoguchi A,Kasai H,Ishibashi T,Iwamura N,To H

    更新日期：2016-08-01 00:00:00

  • Structure-activity relationship: analyses of p-glycoprotein substrates and inhibitors.

    abstract：OBJECTIVE:A large number of structurally and functionally diverse compounds act as substrates or modulators of p-glycoprotein (p-gp). Some of them possess multiple drug resistance (MDR)-reversing activity, but only a small number of them have entered clinical study. In order to uncover the factors which exert a signifi...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章,评审

    doi：10.1046/j.1365-2710.2003.00487.x

    authors： Wang RB,Kuo CL,Lien LL,Lien EJ

    更新日期：2003-06-01 00:00:00

  • Antibiotic prescribing practices in primary and secondary health care facilities in Uttar Pradesh, India.

    abstract：BACKGROUND:Emerging antibiotic resistance in common pathogens is a worldwide problem known to be related to inappropriate overuse of antibiotics. Wide variability in antibiotic use throughout the world is because of various factors, including socio-cultural differences. OBJECTIVE:To study the rate of antibiotic prescr...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/j.1365-2710.2008.00960.x

    authors： Kumar R,Indira K,Rizvi A,Rizvi T,Jeyaseelan L

    更新日期：2008-12-01 00:00:00

  • Direct and indirect comparison of the efficacy and safety of adalimumab, etanercept, infliximab and golimumab in psoriatic arthritis.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Psoriatic arthritis is an autoimmune disease characterized by chronic inflammation of the skin and joints. Anti-TNF drugs reduce the severity of the disease in the long term. This study compares the efficacy and safety of adalimumab, etanercept, infliximab and golimumab in patients with psor...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章,meta分析,评审

    doi：10.1111/jcpt.12045

    authors： Fénix-Caballero S,Alegre-del Rey EJ,Castaño-Lara R,Puigventós-Latorre F,Borrero-Rubio JM,López-Vallejo JF

    更新日期：2013-08-01 00:00:00

  • Determinants of prescribing costs amongst single-handed general practitioners.

    abstract：OBJECTIVE:To investigate the contribution of patient and doctor characteristics in explaining observed variations in prescribing costs between individual doctors. METHOD:Secondary analysis of data collected from general practitioners, Family Health Services Authorities, 1991 Census data set and the Prescription Pricin...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1046/j.1365-2710.2001.00371.x

    authors： Gill PS,Roalfe A

    更新日期：2001-12-01 00:00:00

  • Extremely low dose of 6-mercaptopurine in a Chinese child with acute lymphoblastic leukaemia and multiple pharmacogenetic mutations.

    abstract：WHAT IS KNOWN AND OBJECTIVES:Thiopurines are cornerstone drugs in the treatment of acute lymphoblastic leukaemia (ALL), but their use can be complicated by the incidence of life-threatening leucopenia. CASE DESCRIPTION:We describe a case of a 6-year-old Chinese boy with B-ALL receiving extremely low dose of 6-mercapto...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type：

    doi：10.1111/jcpt.13255

    authors： Zhai XY,Zhou Y,Dong L,Nie AQ,Zhi LJ,Jacqz-Aigrain E,Wang TY,Wang L,Zhao W

    更新日期：2021-02-01 00:00:00

  • Compliance measure development and assessment of theophylline therapy in ambulatory patients.

    abstract：:The objectives of this study were: (a) to develop a drug serum level-based compliance measure which incorporated pharmacokinetic analysis of patient and drug parameters and to compare it to refill records, an indirect measure, and (b) to use that measure to determine whether pharmacist consultation increased complianc...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：

    authors： De Tullio PL,Kirking DM,Arslanian C,Olson DE

    更新日期：1987-02-01 00:00:00

  • A drug usage review of omeprazole.

    abstract：:A drug use review of omeprazole was carried out at two centres in the Yorkshire Region from December 1990 to April 1991. Data collection documents were used and 66 patients in total were audited. Thirteen patients (19.7%) were treated for indications outside the product licence and 18 patients (27.3%) were treated for...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/j.1365-2710.1992.tb01320.x

    authors： Norris CM,McManus PV,Petty D,Kay EA

    更新日期：1992-12-01 00:00:00

  • Influence of calcium antagonist drugs in myasthenia gravis in the elderly.

    abstract：:A number of drugs have been reported to cause neuromuscular blockade and/or to increase weakness in myasthenia gravis. We report on two patients, treated with felodipine and nifedipine for arterial hypertension, who presented with an exacerbation of their myasthenia gravis and a myasthenic syndrome or exacerbation of ...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1046/j.1365-2710.1998.00172.x

    authors： Pina Latorre MA,Cobeta JC,Rodilla F,Navarro N,Zabala S

    更新日期：1998-10-01 00:00:00

  • How much acetaminophen do paediatricians prescribe? A survey among Israeli paediatricians.

    abstract：OBJECTIVE:To describe the current practice of Israeli paediatricians regarding acetaminophen dosing. METHODS:A cross-sectional survey among 200 paediatricians. The paediatricians were questioned of the recommended dose of acetaminophen, and whether they give prescriptions for acetaminophen and instruct their patients ...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/j.1365-2710.2005.00661.x

    authors： Greenberg R,Grossman Z,Goldstein L,Berkovitch M,Kozer E

    更新日期：2005-10-01 00:00:00

  • The stability of carboplatin, diamorphine, 5-fluorouracil and mitozantrone infusions in an ambulatory pump under storage and prolonged 'in-use' conditions.

    abstract：:Drug infusions can be exposed for prolonged periods to 'in-use' conditions where the temperature of an infusion in a holster-worn infusion pump may reach 37 degrees C. In this study, the stability of three cytotoxic drug infusions (carboplatin, 5-fluorouracil and mitozantrone) and one analgesic infusion (diamorphine H...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/j.1365-2710.1991.tb00293.x

    authors： Northcott M,Allsopp MA,Powell H,Sewell GJ

    更新日期：1991-04-01 00:00:00

  • Prasugrel vs. clopidogrel in acute coronary syndrome patients treated with prasugrel.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Current guidelines recommend a combination of clopidogrel and aspirin for management of patients who have experienced an acute coronary syndrome (ACS). Additional antiplatelet agents have been recently approved. Few comparative effectiveness studies are available for these new agents. Accord...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/jcpt.12209

    authors： Olson WH,Ma YW,Laliberté F,Lefebvre P,Crivera C,Schein JR,Fields LE,Dea K,Germain G,Lynch SM

    更新日期：2014-12-01 00:00:00

  • Optimal medical therapy and percutaneous coronary intervention for stable angina: why patients should 'be taking' and 'keep taking' the tablets.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Cardioprotective drug regimens improve outcomes in patients with stable coronary artery disease. Revascularization is recommended for the persistence of symptoms despite optimal medical therapy (OMT) or in patients likely to derive prognostic benefit. Our objective is to comment on recent ev...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/jcpt.12164

    authors： Mohee K,Wheatcroft SB

    更新日期：2014-08-01 00:00:00

  • Association of ABO blood group and antituberculosis drug-induced liver injury: A case-control study from a Chinese Han population.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Antituberculosis drug-induced liver injury (ATLI) is a serious adverse drug reaction, and its pathogenic mechanism is still largely unknown. Rifampin (RIF) has been reported to cause haemolysis due to the production of drug-dependent antibodies, and haemolysis results in an increased level o...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/jcpt.13139

    authors： Tao B,Yang M,Chen H,Pan H,Liu W,Yi H,Tang S

    更新日期：2020-08-01 00:00:00

  • Fenofibrate-induced hepatotoxicity: A case with a special feature that is different from those in the LiverTox database.

    abstract：WHAT IS KNOWN AND OBJECTIVE:We report a special case of fenofibrate-induced acute severe DILI with sudden onset and rapid recovery, which is different from those in the LiverTox database. CASE SUMMARY DESCRIPTION:The acute severe DILI occurred within only 4 days after fenofibrate initial treatment for hypertriglycerid...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type：

    doi：10.1111/jcpt.13042

    authors： Ma S,Liu S,Wang Q,Chen L,Yang P,Sun H

    更新日期：2020-02-01 00:00:00

  • A Computer Prescribing Order Entry-Clinical Decision Support system designed for neonatal care: results of the 'preselected prescription' concept at the bedside.

    abstract：WHAT IS KNOWN:The neonatal intensive care units (NICUs) are at the highest risk of drug dose error of all hospital wards. NICUs also have the most complicated prescription modalities. The computerization of the prescription process is currently recommended to decrease the risk of preventable adverse drug effects (pADEs...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/jcpt.12474

    authors： Gouyon B,Iacobelli S,Saliba E,Quantin C,Pignolet A,Jacqz-Aigrain E,Gouyon JB

    更新日期：2017-02-01 00:00:00

  • Treatment of irritable bowel syndrome.

    abstract：WHAT IS KNOWN AND OBJECTIVE:The complexity and diversity of irritable bowel syndrome's (IBS) presentation make treatment difficult. Although there are reviews and guidelines for treating IBS, they focus on the efficacy of medications for IBS symptoms using high-priority endpoints, leaving those of lower priority largel...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章,评审

    doi：10.1111/j.1365-2710.2010.01177.x

    authors： Trinkley KE,Nahata MC

    更新日期：2011-06-01 00:00:00

  • Compatibility of ropivacaine with morphine, sufentanil, fentanyl, or clonidine.

    abstract：BACKGROUND:Ropivacaine hydrochloride (HCl) ('Naropin') is a long-acting local anaesthetic agent, administered epidurally to patients undergoing various surgical procedures. A combination of local anaesthetic and opioid is often administered for the management of severe pain to ensure that a minimal dose of each is used...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1046/j.1365-2710.2002.00386.x

    authors： Oster Svedberg K,McKenzie J,Larrivee-Elkins C

    更新日期：2002-02-01 00:00:00

  • Study of microbial contamination and dosing accuracy of oral dispensers.

    abstract：BACKGROUND AND OBJECTIVE:The optimal administration of liquid medications requires accurate dose delivery. This is particularly important in the treatment of infants and children, as well as elderly people, who are more sensitive to dosage errors. Previous studies revealed significant dosage inaccuracies with measuring...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type： 杂志文章

    doi：10.1111/j.1365-2710.2009.01082.x

    authors： Dockhorn S,Feuersenger D,Schuenemann S,Knauf B,Duerr S,Schubert-Zsilavecz M,Abdel-Tawab M

    更新日期：2010-06-01 00:00:00

  • Hepatotoxicity caused by mebendazole in a patient with Gilbert's syndrome.

    abstract：WHAT IS KNOWN AND OBJECTIVE:Mebendazole (MBZ) is a broad-spectrum antihelminthic agent of the benzimidazole type. Although MBZ has been reported to cause hepatic injury, case reports of severe hepatic injury are very rare. We report a case of severe hepatitis after administration of MBZ in a patient with Gilbert's synd...

    journal_title：Journal of clinical pharmacy and therapeutics

    pub_type：

    doi：10.1111/jcpt.13033

    authors： Tolomeo M,Colomba C,Meli M,Cascio A

    更新日期：2019-12-01 00:00:00